Form Type: 4

SEC EDGAR Link
Accession Number:0000899866-21-000052
Date:2021-07-14
Issuer: ALEXION PHARMACEUTICALS, INC. (ALXN)
Original Submission Date:

Reporting Person:

CARINO TANISHA
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BOULEVARD BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, PAR VALUE $.0001 PER SHARE 2021-07-14 A 25,813 a $0.00 59,226 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 on july 14, 2021 the leadership and compensation committee certified that certain performance metrics under previously granted performance stock units were satisfied. these performance stock units were previously granted in february 2020 under the 2017 stock incentive plan.
WhaleWisdom Logo

Elevate your investments